April
23
  12:20:26 AM

Sperm bank to be sued for defective product

A US court has ruled that a sperm bank can be sued for selling sperm that causes a child to have a genetic defect. The case was brought on behalf of a 13-year-old girl with Fragile-X syndrome, a common cause of mental retardation and shines more light on the market for sperm. According to the judgement, in 1994, Donna Donovan found a company which promised first-class sperm. Idant Laboratories guaranteed that its semen was exceptionally safe, that its screening standards were excellent, and that its donors had been rigorously screened for a good genetic background. Unfortunately donor G738 was a carrier for Fragile X. The child's problems became apparent in 1998, but two doctors engaged by Idant still insisted that they were not related to Fragile-X syndrome nor to the donated sperm. Ms Donovan accepted this and it was not until a case report about her daughter was published in a medical journal that she realised that the sperm donor had definitely been a carrier. The case is still in its early stages, but no doubt will be watched anxiously by all sperm merchants. ~Wall Street Journal, Apr 9

 

 Search BioEdge

 Subscribe to BioEdge newsletter
rss Subscribe to BioEdge RSS feed

 Best of the web

 Recent Posts
Lost in surrogacy’s Bermuda Triangle
3 Feb 2012
Scores of UK patients die with bedsores, infections and malnutrition
3 Feb 2012
Crackdown on illegal abortions restores Taiwan sex ratio
3 Feb 2012
Immigrant dad will miss out on transplant
3 Feb 2012
North Carolina may compensate victims of eugenics program
2 Feb 2012

 Tags
surrogacy, sperm donation, Canada, IVF, bioethics, India, organ donation, genetic testing, China, Down syndrome, clinical trials, law, HFEA, sex selection, human drama, Australia, commercialization, abortion, embryonic stem cells, UK, informed consent, Netherlands, organ trafficking, research, neuroscience, US, euthanasia, suicide, stem cells, assisted suicide,